cognitive cybersecurity intelligence

News and Analysis

Search

Novo Nordisk slashing prices for weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus

Novo Nordisk slashing prices for weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus


Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, the list price for Wegovy, Ozempic and Rybelsus, Novo’s semaglutide products, will be $675 across the board in the U.S. This reduction…

Source: thehill.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Top 10 Best VPN For Chrome in 2026

Top 10 Best VPN For Chrome in 2026

In ever-changing technology and networks, privacy is becoming increasingly difficult to achieve. People are so used to using the Internet and IoT devices that the